Respiratory Care Devices Market to Reach $47.9 billion, Globally, by 2033 at 7.6% CAGR: Allied Market Research
The use of respiratory care devices is expected to increase in the near future, owing to the spiraling rise in...
Genetic Testing
Kindbody Unveils Next-Generation Fertility Platform to Improve Outcomes, Accelerate Affordability and Intelligence in Reproductive Care
Kindbody's Enhanced Platform Integrates AI, Clinical Innovation, and Whole‑Family Support to Improve Outcomes, Reduce Costs, and Elevate Patient ExperienceNEW YORK,...
Nuclear Medicine Equipment Market to Reach $16.1 billion, Globally, by 2033 at 11.3% CAGR: Allied Market Research
Surge in the prevalence of chronic diseases such as cancer & cardiovascular diseases and advancements in technology drive the growth...
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
Partnering with Texas pathology group enables a genetics-focused strategy to address the hidden epidemic of celiac diseaseIRVINE, Calif. and SAN...
IoT in Healthcare Market to Reach US$594.5 Bn by 2035 at 23.85% CAGR | Vantage Market Research
NEW YORK, Feb. 2, 2026 /PRNewswire/ -- The Global IoT in Healthcare Market is entering a high-impact growth phase as...
10X Health System and Verséa Discovery Launch 10X MitoScreen™, a Next-Generation Mitochondrial Assessment Test
A clinically robust mitochondrial assessment that transforms advanced cellular testing into actionable insights for optimized energy, metabolism, and personalized performance. SCOTTSDALE,...
Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
SALT LAKE CITY, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing...
Top Five Health Care Trends for 2026: How New Technology Is Transforming Patient Care
AUSTIN, Texas, Jan. 6, 2026 /PRNewswire/ -- From wearable devices that catch health issues sooner to artificial intelligence (AI) tools...
Best Horvath Clock Test (2026): TruDiagnostic Awarded for Accurate GrimAge and PhenoAge Analysis by Better Business Advice
NEW YORK, Dec. 23, 2025 /PRNewswire/ -- Better Business Advice is recognizing TruDiagnostic in its 2026 assessment of Horvath Clock testing solutions....
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection...
GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models
AI-Driven Risk Prediction for Breast, Prostate and Pancreatic CancersTOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (Japanese Name:...
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
Phase 2 clinical trial initiated to evaluate SEMA3A mAb as potential treatment for Alport syndromeMilestone payment to Evotec expected upon...
MyOme and Ms.Medicine Announce Strategic Partnership to Redefine Personalized Primary Care Through Genomics
MENLO PARK, Calif. and CINCINNATI, Dec. 3, 2025 /PRNewswire/ -- MyOme, a leading clinical whole-genome testing and polygenic risk modelling...
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and strategic investments aimed at supporting margin improvement and...
Illume Fertility Launches Comprehensive Online Finance Hub to Help Patients Navigate the Cost of Fertility Care
New resource provides clear guidance on insurance, financing, grants, and medication savings programs to make family building more accessibleNORWALK, Conn.,...
Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home injection from...
MyOme Launches First Integrated Polygenic Risk Score for Prostate Cancer to Advance Early Detection and Personalized Prevention
New whole-genome test uncovers hidden genetic risk beyond traditional screening, empowering earlier and more precise care for millions of men....
The Rise of Advanced Maternal Age IVF: BaseCare Medical’-B(2170.HK) AI “Undisturbed Culture” Empowers Intelligent Assisted Reproduction
SUZHOU, China, Nov. 19, 2025 /PRNewswire/ -- Data from the keynote report at the 18th Annual Conference of the Chinese...
Pinnacle Fertility Expands National Network with the Addition of Tulsa Fertility Center
SCOTTSDALE, Ariz., Nov. 14, 2025 /PRNewswire/ -- Tulsa Fertility Center, a leading provider of reproductive medicine and one of Oklahoma's...
Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
SALT LAKE CITY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing...